Question 1

- question: "Is it safe to take ketamine at home without a doctor physically present?

Accepted Answer

At-home ketamine therapy can be safe when delivered through a reputable telehealth program with proper medical screening, appropriate dosing, and ongoing clinical monitoring. Published safety data from established telehealth ketamine providers shows that serious adverse events are rare when patients are properly screened and follow their treatment protocols. See our [at-home safety data](/safety/at-home-safety-data/) article for the evidence. The sublingual route used in at-home programs has a lower risk profile than IV administration due to lower peak blood concentrations and a more gradual onset of effects.

Question 2

What are the most common side effects of sublingual ketamine?

Accepted Answer

The most common side effects include nausea (reported by approximately 15-25% of patients), dizziness, fatigue, dissociation (a feeling of detachment from your body or surroundings), increased blood pressure, and a bitter taste from the medication. Most side effects are mild to moderate and resolve within one to two hours after the session. Nausea can often be managed with anti-nausea medication prescribed by your provider. Dissociation, while potentially unsettling for first-time patients, is generally considered a normal part of the therapeutic experience.

Question 3

What should I do if I have a bad reaction during a session?

Accepted Answer

If you experience distressing psychological effects such as severe anxiety or panic, try grounding techniques like opening your eyes, focusing on your breathing, touching a familiar object, or having your support person speak to you calmly. If symptoms are severe or you feel unsafe, contact your provider's emergency line immediately. For medical emergencies — such as difficulty breathing, chest pain, severe vomiting, or loss of consciousness — call 911 immediately. Having a sober support person present is one of the most important safety measures.

Question 4

Who should NOT take ketamine at home?

Accepted Answer

Ketamine therapy is not appropriate for everyone. Contraindications include uncontrolled hypertension, active psychosis or schizophrenia, untreated substance use disorders (particularly with ketamine or other dissociatives), severe liver disease, pregnancy or breastfeeding, and certain cardiovascular conditions. Patients with a history of aneurysm, elevated intracranial pressure, or unstable angina should not receive ketamine. Your provider should screen for all contraindications during the initial evaluation. See our full [contraindications guide](/safety/contraindications/) for details.

Question 5

Do I need someone with me during treatment sessions?

Accepted Answer

Most telehealth ketamine providers strongly recommend having a sober support person present during your sessions, particularly for your first several treatments. This person should be a trusted adult who can assist you if needed, call for help in an emergency, and ensure you remain safe during the dissociative period. Some providers require a support person for the first session as a condition of treatment. Even as you become experienced with the medication, having someone available is a prudent safety measure.

Question 6

Can ketamine be addictive?

Accepted Answer

Ketamine has abuse potential, which is why it is classified as a Schedule III controlled substance. However, when used in prescribed therapeutic doses under medical supervision, the risk of developing ketamine dependence is considered low. Therapeutic protocols use controlled dosing at set frequencies, which is substantially different from recreational use patterns. Your provider should monitor for signs of tolerance or misuse as part of ongoing care. If you have a personal history of substance use disorder, discuss this thoroughly with your provider during evaluation.

Question 7

What are the long-term safety concerns with ketamine therapy?

Accepted Answer

Long-term concerns identified primarily in research on chronic recreational use include potential effects on bladder function (interstitial cystitis), liver function, and cognitive performance. These effects are associated with high-dose, frequent, and prolonged use patterns that differ substantially from therapeutic protocols. Clinical monitoring during treatment should include periodic assessment of urinary symptoms, liver function, and cognitive status. The therapeutic doses and frequencies used in telehealth programs are significantly lower than those associated with chronic use complications.

Question 8

How does the provider monitor my safety remotely?

Accepted Answer

Reputable telehealth ketamine providers use multiple layers of remote safety monitoring. These include pre-treatment screening and ongoing medical evaluation, regular follow-up appointments via video to assess treatment response and side effects, validated symptom questionnaires (such as PHQ-9 and GAD-7) to track clinical outcomes, secure messaging for questions or concerns between appointments, and on-call clinical staff available during scheduled treatment times. Some providers also use apps to track session data and mood between appointments.

Safety FAQ: At-Home Ketamine Treatment

Frequently Asked Questions

Related Reading

Choosing a Telehealth Ketamine Provider: FAQ

Cost and Payment FAQ: Telehealth Ketamine Therapy

State Regulations FAQ: Telehealth Ketamine by State